model confidence 90%
Repeals Chapter 170A (Texas Heartbeat Act banning most abortions after detection of embryonic cardiac activity) and other statutes that prohibit or limit abortions, so more legal access to abortion at later gestations.
The following provisions are repealed: (1) Chapter 170A, Health and Safety Code;
✓ Quote verified word for word in the bill text
model confidence 85%
Amends medication abortion rules to allow provision per 2013 ACOG guidelines in addition to FDA final printed label, and removes some prior restrictions, so more legal access to medication abortion.
A person may provide the abortion-inducing drug in the dosage amount prescribed by the clinical management guidelines defined by the American College of Obstetricians and Gynecologists Practice Bulletin as those guidelines existed on January 1, 2013.
✓ Quote verified word for word in the bill text
Restricts abortion access model confidence 70%
Updates and slightly modifies reporting requirements for abortion complications and physician requirements for medication abortion (examination, documentation, follow-up visit), so minor additional regulation of providers.
The reporting requirements of this section apply only to: (1) a physician who: (A) performs at an abortion facility an abortion that results in an abortion complication diagnosed or treated by that physician; or (B) diagnoses or treats at an abortion facility an abortion complication that is the result of an abortion performed by another physician at the facility; or (2) a health care facility that is a hospital, abortion facility, freestanding emergency medical care facility, or health care facility that provides emergency medical care, as defined by Section 773.003.
✓ Quote verified word for word in the bill text
Stage: Filed · step 1 of 6
Why the model tagged it this way: The bill primarily expands abortion access by repealing the Texas Heartbeat Act (Chapter 170A) and multiple other statutes that banned or restricted abortions (including medication abortion limits), while making minor adjustments to complication reporting and medication protocols that add limited regulatory requirements.
| Date | Chamber | Action |
|---|---|---|
| 2026-11-09 | H | Filed |